Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus ointment in moderate to severe atopic dermatitis
NCT00691145Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2002
- Primary completion
- Feb 2005
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Envarsus XR in atopic dermatitis (AD), sponsored by Astellas Pharma. Started Oct 2002; status: completed.
02
Drugs
Envarsus XR
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00691145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00691145.